En Es
Categories

Industry News

Eppendorf Introduces Multipurpose Centrifuge 5910 Ri to Accelerate Results

By Labmedica International staff writers
16 Apr 2021

Image: Eppendorf Centrifuge 5910 Ri (Photo courtesy of Eppendorf AG)Eppendorf AG (Hamburg, Germany) has introduced a new centrifuge designed to increase efficiency in the laboratory, Centrifuge 5910 Ri, a successor to the company’s popular Centrifuge 5910 R.

The Centrifuge 5910 Ri has been the flagship of Eppendorf multipurpose centrifuge portfolio that has been providing customers worldwide with outstanding versatility and ease of use since its launch in 2018. With the introduction of Centrifuge 5910 Ri, Eppendorf now offers scientists advanced features to simplify and accelerate the centrifugation steps of their workflow. An innovative touchscreen interface allows for quick setting of desired parameters while three levels of user management and new documentation options provide enhanced security and traceability. The optional connection to the new VisioNize Digital Lab Suite enables remote monitoring of the device, notification of alarms and events, and convenient access to important documents such as certificates and operating manuals.

A large selection of rotors and adapters facilitates a wide range of applications, while the unique Universal rotor saves time by allowing the centrifugation of, for example, 50 mL conical tubes, plates and 250 mL bottles without the need to change the rotor, rotor buckets or adapters. High capacity and performance combined with an intuitive user interface for fast, error-free operation make the new Eppendorf Centrifuge 5910 Ri well-equipped to meet the needs of modern labs now and into the future.




E-mail Print
FaceBook Twitter Google+ Linked in

EPPENDORF AG

Eppendorf is a life science company that develops and sells instruments, consumables, and services for liquid-, sample-, and cell handling in laboratories across the world. Its product range includes pipettes and pipette tips, centrifuges and microcentrifuge tubes, thermal cyclers, sample-protecting deepwell plates, cell manipulation systems and microcapillaries, ultra-low temperature freezers, shakers, incubators and bioprocessing equipment.
More info

Additional news

15 Jun 2021
Quidel Receives Amended FDA Emergency Use Authorization for New AI-Powered Sofia Q Rapid Antigen Test Device
Quidel Corporation (San Diego, CA, USA) has received an amended Emergency Use Authorization (EUA) from the US Food and Drug Administration (FDA) allowing the company to market Sofia Q, its latest addition to the Sofia and Sofia 2 line of Fluorescent Immunoassay Analyzers (FIA).
Read More
15 Jun 2021
Global PET-CT Scanner Device Market to Reach USD 3.34 Billion by 2028
The global PET-CT scanner device market size is expected to register a CAGR of 6.6% from 2021 to 2028 to reach USD 3.34 billion by 2028, driven primarily by the increasing need to overcome the shortfalls of CT and PET in oncology imaging.
Read More
11 Jun 2021
Global Clinical Chemistry Analyzers Market to Reach USD 15.97 Billion by 2028
The global clinical chemistry analyzers market is projected to grow at a CAGR of 4.25% from USD 11.45 billion in 2020 to USD 15.97 billion by 2028, driven by growth in technology, rising global population, technological improvements in point of care testing devices, and development of laboratory automation.
Read More
09 Jun 2021
Global COVID-19 Saliva Screening Test Market to Reach USD 3,406.2 Billion by 2023
The global COVID-19 saliva screening test potential market size is expected to expand at a CAGR of 4.8% from USD 2955.9 billion in 2021 to USD 3,406.2 billion by 2023, driven by a rise in the demand for rapid, efficient, saliva-based screening tests.
Read More
20 May 2021
Global Lateral Flow Assays Market to Reach USD 13.85 Billion by 2027 Due to Benefits of Rapid Tests and Growing Demand for POC Testing
The global lateral flow assays market is expected to grow at a CAGR of 8.8% from 2020 to 2027 to reach USD 13.85 billion by 2027, driven mainly by the benefits of LFA-based rapid tests over laboratory testing and growing demand for point-of-care testing.
Read More
18 May 2021
PerkinElmer to Acquire UK In-Vitro Diagnostics Company Immunodiagnostic Systems
PerkinElmer, Inc. (Waltham, MA; USA) and Immunodiagnostic Systems Holdings PLC (IDS; Boldon, Tyne and Wear, UK) have reached an agreement whereby PerkinElmer will acquire IDS for approximately USD 155 million.
Read More
14 May 2021
Siemens Launches its Fastest, Single-Source CT Scanner, Somatom X.ceed
Siemens Healthineers (Erlangen, Germany) has launched Somatom X.ceed, a new high-resolution, high-speed CT (computed tomography) scanner engineered specifically for the most challenging clinical areas where time and precision are of essence.
Read More
14 May 2021
Carestream Unveils Groundbreaking AI-Based Technology that Advances X-Ray Image Quality
Carestream Health (Rochester, N.Y., USA) has released Smart Noise Cancellation (SNC), a groundbreaking artificial intelligence (AI)-based technology that greatly improves image quality - producing images that are significantly clearer than with standard processing.
Read More
12 May 2021
Artificial Intelligence (AI) Program Accurately Predicts Lung Cancer Risk from CT Images
An artificial intelligence (AI) program accurately predicts the risk that lung nodules detected on screening CT will become cancerous, according to a study published in the journal Radiology.
Read More
Copyright © 2000-2021 TradeMed.com. All rights reserved. | Terms And Conditions